HOME >> BIOLOGY >> NEWS
ACS News Service Weekly PressPac -- March 28, 2007

ome scientists dismissed the original 1989 cold fusion experiments by Stanley Pons and Martin Fleischmann as "bad" science due to alleged errors in calorimetric systems, or heat measurement, that could have led to erroneous reports that the excess heat produced was nuclear in origin.

Using more precise calorimetric techniques, a new study by Fleischmann and colleague Melvin Miles reports evidence that the excess heat generated is nuclear and not the result of calorimetric errors. "Our work shows that cold fusion effects are real, but we cannot assess if this excess heat can become useful. Much more research work is needed to answer such questions," says co-author Miles.

CONTACT:
Melvin H. Miles, Ph.D.
University of LaVerne in Calif.
LaVerne, Calif.
Phone: Office: 760-375-9258
Email: mmiles@ulv.edu


ARTICLE # 6 EMBARGOED FOR 9 A.M., EASTERN TIME, April 2, 2007

Leveraging Disorder
Chemical & Engineering News

One of the basic tenets of biology is that the structure of a protein determines its function, but intrinsically disordered proteins, which are unstructured or contain highly unstructured regions, dont seem to follow this rule. Now, a growing number of researchers are finding that these disordered proteins have important biological functions and are involved in disease processes ranging from cancer to Alzheimers disease. An article on these mysterious proteins is scheduled for the April 2 issue of Chemical & Engineering News, the ACS weekly newsmagazine.

Researchers now believe that these disordered proteins confer plasticity and flexibility to proteins, thereby allowing the signaling networks these proteins control to rapidly respond to their cells environment, according to the article by C&EN Associate Editor Sarah Everts. She interviewed several scientists who have provided new insights into these fasc
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
28-Mar-2007


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- April 11, 2007
8. ACS News Service Weekly PressPac -- March 21, 2007
9. ACS News Service Weekly PressPac -- March. 14, 2007
10. ACS News Service Weekly PressPac -- Feb. 21, 2007
11. ACS News Service Weekly PressPac -- February 14, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  Ascendis Pharma A/S (Nasdaq: ASND), a ... to address significant unmet medical needs in rare ... year ended December 31, 2016. ... as we broadened our pipeline and pursued our ... company with an initial focus on endocrinology," said ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
(Date:3/22/2017)... BEACH, Florida , March 22, 2017 ... ... for various cancer conditions are being pressured as of late ... therapy for cancer pain management has a dramatic impact on ... up research and development activities for identifying new forms of ...
Breaking Biology Technology:
Cached News: